Skip to main content
. 2020 Oct 12;143(4):298–309. doi: 10.1161/CIRCULATIONAHA.120.050391

Table 2.

Efficacy of Dapagliflozin on the Primary and Secondary Outcomes According to Baseline eGFR

graphic file with name cir-143-298-g002.jpg